Logos Global Management LP
- SEC CIK
- 0001792126
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/17 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 57
- 較 2021 年第 1 季 +4
- 總值
- $11.7 億
- 較 2021 年第 1 季 +$1.41 億 (+13.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ALXOAlx Oncology Holdings Inc | COM | 3,156,981 | $1.73 億 | 14.8% | 00.0% | 不變 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,743,875 | $1.05 億 | 9.0% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 2,732,501 | $5,435 萬 | 4.7% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 758,265 | $4,569 萬 | 3.9% | +758,265 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,054,392 | $4,322 萬 | 3.7% | −1,150,000−35.9% | 減碼 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 1,100,000 | $4,027 萬 | 3.5% | +1,038,000+1,674.2% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 325,000 | $3,705 萬 | 3.2% | +125,000+62.5% | 加碼 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 1,070,762 | $3,291 萬 | 2.8% | +1,070,762 | 新進 | 歷史 |
| TILInstil Bio, Inc. | COM | 1,696,850 | $3,278 萬 | 2.8% | −150,000−8.1% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 850,000 | $3,243 萬 | 2.8% | +600,000+240.0% | 加碼 | 歷史 |
| NKTXNkarta, Inc. | COM | 1,002,382 | $3,177 萬 | 2.7% | −258,495−20.5% | 減碼 | 歷史 |
| TPTXTurning Point Therapeutics, Inc. | COM | 400,000 | $3,121 萬 | 2.7% | +260,000+185.7% | 加碼 | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 1,329,602 | $3,095 萬 | 2.7% | +395,000+42.3% | 加碼 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,215,000 | $3,024 萬 | 2.6% | −195,000−13.8% | 減碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,125,000 | $2,927 萬 | 2.5% | +1,125,000 | 新進 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 989,095 | $2,902 萬 | 2.5% | +989,095 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 1,400,000 | $2,771 萬 | 2.4% | +700,000+100.0% | 加碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,231,812 | $2,628 萬 | 2.3% | +175,000+16.6% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 350,000 | $2,212 萬 | 1.9% | +350,000 | 新進 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 715,000 | $2,171 萬 | 1.9% | −85,000−10.6% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 939,545 | $2,087 萬 | 1.8% | +939,545 | 新進 | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 1,162,320 | $1,814 萬 | 1.6% | +1,162,320 | 新進 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 2,500,000 | $1,578 萬 | 1.4% | +1,300,000+108.3% | 加碼 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 724,333 | $1,574 萬 | 1.3% | +724,333 | 新進 | 歷史 |
| LONALeonaBio, Inc. | COM | 1,410,812 | $1,445 萬 | 1.2% | +400,000+39.6% | 加碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 547,122 | $1,365 萬 | 1.2% | +547,122 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 2,300,000 | $1,249 萬 | 1.1% | +1,500,000+187.5% | 加碼 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 780,331 | $1,213 萬 | 1.0% | +780,331 | 新進 | – |
| ACRSAclaris Therapeutics, Inc. | COM | 675,000 | $1,185 萬 | 1.0% | +675,000 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,420,500 | $1,152 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| PRLDPrelude Therapeutics Inc | COM | 400,000 | $1,145 萬 | 1.0% | +400,000 | 新進 | 歷史 |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 800,000 | $1,114 萬 | 1.0% | +400,000+100.0% | 加碼 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 800,000 | $1,110 萬 | 1.0% | +500,000+166.7% | 加碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,339,793 | $1,060 萬 | 0.9% | +1,115,722+497.9% | 加碼 | 歷史 |
| LABPLandos Biopharma, Inc. | COM | 899,106 | $1,039 萬 | 0.9% | +165,106+22.5% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 330,000 | $1,029 萬 | 0.9% | −570,000−63.3% | 減碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 270,000 | $858.3 萬 | 0.7% | +270,000 | 新進 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 507,923 | $746.1 萬 | 0.6% | +507,923 | 新進 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 288,458 | $742.8 萬 | 0.6% | −125,000−30.2% | 減碼 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 206,564 | $705.6 萬 | 0.6% | +6,564+3.3% | 加碼 | 歷史 |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 300,000 | $681.0 萬 | 0.6% | +300,000 | 新進 | 歷史 |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 3,190,000 | $673.1 萬 | 0.6% | +3,190,000 | 新進 | – |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 2,000,000 | $660.0 萬 | 0.6% | −300,000−13.0% | 減碼 | – |
| ALGSAligos Therapeutics, Inc. | COM | 212,785 | $433.9 萬 | 0.4% | −263,762−55.3% | 減碼 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 112,928 | $427.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IMAImageneBio, Inc. | COM | 299,853 | $421.0 萬 | 0.4% | −120,000−28.6% | 減碼 | 歷史 |
| ANNXAnnexon, Inc. | COM | 159,622 | $359.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 200,000 | $227.6 萬 | 0.2% | 00.0% | 不變 | – |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 200,000 | $214.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PASGPassage BIO, Inc. | COM | 125,010 | $165.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FS Development Corp II30318F100 | COM CL A | 123,543 | $123.3 萬 | 0.1% | −176,457−58.8% | 減碼 | – |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 100,000 | $102.0 萬 | 0.1% | −200,000−66.7% | 減碼 | 歷史 |
| RACBResearch Alliance Corp. II | COM CL A | 100,000 | $101.4 萬 | 0.1% | −200,000−66.7% | 減碼 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 37,069 | $84.4 萬 | 0.1% | +37,069 | 新進 | 歷史 |
| MLTXMoonLake Immunotherapeutics | COM CL A | 50,000 | $51.8 萬 | <0.1% | −150,000−75.0% | 減碼 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 66,666 | $17.3 萬 | <0.1% | 00.0% | 不變 | – |
| MREOMereo BioPharma Group plc | SPON ADS | 46,984 | $14.9 萬 | <0.1% | +46,984 | 新進 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| RAPTRAPT Therapeutics, Inc. | COM | – | $2,384 萬 |
2021 年第 1 季之後清倉（14 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BTAIQBioXcel Therapeutics, Inc. | COM | 400,000 | $1,726 萬 | 1.7% | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 260,920 | $1,014 萬 | 1.0% | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 480,000 | $926.4 萬 | 0.9% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 550,000 | $919.1 萬 | 0.9% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 125,000 | $545.4 萬 | 0.5% | 歷史 |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 500,000 | $525.5 萬 | 0.5% | – |
| BOLTBolt Biotherapeutics, Inc. | COM | 150,000 | $493.7 萬 | 0.5% | 歷史 |
| VIRXViracta Therapeutics, Inc. | COM | 470,000 | $434.8 萬 | 0.4% | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 230,000 | $336.0 萬 | 0.3% | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 100,000 | $330.4 萬 | 0.3% | 歷史 |
| LHDXLucira Health, Inc. | COM | 250,000 | $302.5 萬 | 0.3% | 歷史 |
| CNTBConnect Biopharma Holdings Ltd | ADS | 150,000 | $277.5 萬 | 0.3% | 歷史 |
| EAREargo, Inc. | COM | 50,000 | $249.8 萬 | 0.2% | 歷史 |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 33,333 | $14.4 萬 | <0.1% | – |